Vectorite Biomedical

Vectorite Biomedical Debt / Assets

The Debt-to-Assets Ratio of Vectorite Biomedical (4170.TWO) as of Oct 19, 2026 is 0.05.

Debt / Assets

0.05

Last updated:

Debt-to-Assets Ratio of Vectorite Biomedical is 2019 0.05 . Debt-to-Assets Ratio of Vectorite Biomedical was 2018 0.00 . It decreases by % higher compared to the previous year.

The Vectorite Biomedical Debt / Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Debt / Assets
Date
Debt / Assets
Jan 1, 2014
0.03 TWD
Jan 1, 2015
0.05 TWD
Jan 1, 2016
0.10 TWD
Jan 1, 2017
0.00 TWD
Jan 1, 2018
0.00 TWD
Jan 1, 2019
0.05 TWD
The Vectorite Biomedical Debt / Assets history
YEARDebt / AssetsYoY
0.05—
0.00—
0.00-100.00%
0.10+91.32%
0.05+82.94%
0.03—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Vectorite Biomedical Stock analysis

What does Vectorite Biomedical do? Vectorite Biomedical Inc, headquartered in Taipei, Taiwan, operates in the Health Care sector within the Biotechnology industry. Listed on 28 December 2023, the company specializes in developing dendritic cell (DC) vaccines and natural killer (NK) cell preparations for cancer treatment. It offers immune cell collection, processing, storage, and safety testing services, along with ODM/CDMO services, medical consulting, and laboratory quality management. Products are primarily sold within Taiwan. Vectorite Biomedical is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Vectorite Biomedical stock

Debt-to-Assets Ratio of Vectorite Biomedical is 0.05 in 2019.

On Eulerpool you can find the complete historical development of Debt-to-Assets Ratio Vectorite Biomedical since 2006 – with annual values, charts, and detailed analysis.

The Debt-to-Assets ratio measures what percentage of a company's assets are financed through debt. Higher ratios indicate greater financial risk.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Debt-to-Assets Ratio's Vectorite Biomedical with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Leverage — Vectorite Biomedical

Debt-to-EquityNet Debt / EBITDAInterest CoverageCurrent RatioQuick RatioCash RatioDebt / AssetsFinancial LeverageEquity RatioLT Debt/EquityNet Debt/EquityDebt/EBITDADSCRFinancial Debt RatioOCF/DebtFCF/DebtNet Debt/FCFDebt/Market Cap

All Key Metrics — Vectorite Biomedical